Dayanan, Albert T.

HRN: 20-72-87  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
11/21/2023
11/27/2023
PO
400000
Q8
Oral Thrush
Checking Final Appropriateness 
11/21/2023
CEFTRIAXONE 1G (VIAL)
11/21/2023
11/27/2023
IV
2g
OD
Pharyngitis; T/c Pharyngeal Abscess
Checking Final Appropriateness 
11/22/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
11/22/2023
11/29/2023
IV
400 Now Then 200 OD
OD
Candidiasis
Checking Final Appropriateness 
11/22/2023
AZITHROMYCIN 500MG TABLET (TAB)
11/22/2023
11/26/2023
PO
500
OD
CAP
Checking Final Appropriateness 
12/01/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/01/2023
12/01/2023
IV
4.5g
Loading Dose (now)
Sepsis
Checking Final Appropriateness 
12/01/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/01/2023
12/08/2023
IV
2.25g
Q8
Sepsis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: